BARCLAYS PLC - INNATE PHARMA S A ownership

INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 9 filers reported holding INNATE PHARMA S A in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of INNATE PHARMA S A
ValueSharesWeighting
Q3 2023$10.0%4120.0%0.00%
Q2 2023$10.0%4120.0%0.00%
Q1 2023$1
-50.0%
4120.0%0.00%
Q4 2022$2412
+235.0%
0.00%
Q3 2022$0
-100.0%
123
-94.4%
0.00%
Q2 2022$6,000
-45.5%
2,179
-36.1%
0.00%
Q1 2022$11,0003,4110.00%
Other shareholders
INNATE PHARMA S A shareholders Q3 2023
NameSharesValueWeighting ↓
Rubric Capital Management LP 931,673$6,382,0000.73%
ADAGE CAPITAL PARTNERS GP, L.L.C. 500,000$3,425,0000.01%
WELLINGTON MANAGEMENT GROUP LLP 1,351,538$9,866,0000.00%
MILLENNIUM MANAGEMENT LLC 72,657$530,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 12,441$85,0000.00%
Steward Partners Investment Advisory, LLC 1,100$8,0000.00%
OSAIC HOLDINGS, INC. 2,000$14,0000.00%
View complete list of INNATE PHARMA S A shareholders